11-28-2018 08:18 AM CET - Advertising, Media Consulting, Marketing Research
Print

Cell-based Assays Market Competitive Analysis by Leading Industry Players Thermo Fisher Scientific Inc., BD, Danaher, General Electric Company, Charles River Laboratories Inc., Lonza, Eppendorf AG, Agilent Technologies, Bruker, Stryker, Quest Diagnostics,

Press release from: Data Bridge Market Research
Cell-based Assays Market
Cell-based Assays Market


This report contains all the company profiles of the key players and brands that making moves such as developments, product launches, joint ventures, merges and accusations which affect the Global Cell-based Assays Market, along with the company profiles the report also contains the market restrains and drivers which are derived through SWOT analysis of the Global Cell-based Assays Market.

The report also gives an in-depth idea about what the market definition, classifications, applications and market trends are, the report also contains the CAGR figures for the historic year 2016 base year 2017 and forecast year 2018-2025.

Get Exclusive Sample PDF Report at databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Major Market Drivers and Restraints:

• Increasing research activities in drug discovery
• Technological advancement in the assays
• Rise in demand for biological drugs
• Rising need for toxicity screening in drugs
• Rising incidence of chronic diseases
• Government expenditure for research
• High price of instruments
• Stringent regulations for reagent use

Data Bridge Market Research Adds “Global Cell-based Assays Market – Industry Trends and Forecast to 2025” new report to its research database. The report spread No of Pages: 350 No of Figures: 60 No of Tables: 220 in it.

Major Market Competitors:

• Thermo Fisher Scientific Inc.,
• BD,
• Danaher,
• General Electric Company,
• Charles River Laboratories Inc.,
• Lonza,
• Eppendorf AG,
• Agilent Technologies,
• Bruker,
• Stryker,
• Quest Diagnostics,
• Bio-Rad Laboratories Inc.,
• Illumina Inc.,
• 10x Genomics,
• Abcam plc,
• QIAGEN,
• Promega Corporation,
• Merck KGaA,
• Sysmex,
• FLUIDIGM,
• Cell Signaling Technology Inc.,
• DiscoverX Corporation,
• Cisbio,
• Cell Biolabs Inc.,
• BioTek Instruments Inc.,
• SGS SA,
• Selexis SA,
• Cambridge Biomedical Inc.,
• BioAgilytix Labs. and
• Fluofarma among others.

For More Inquiry Contact us at databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Market Analysis: Global Cell-based Assays Market

The cell-based assays market accounted to USD 12.27 billion in 2016 growing at a CAGR of 8.43% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Table of Contents

1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global, By Component
7. Product Type
8. Delivery
9. Industry Type
10. Geography
10.1. Overview
10.2. North America
10.3. Europe
10.4. Asia-Pacific
10.5. South America
10.6. Middle East & Africa
11. Company Landscape
12. Company Profiles
13. Related Reports

Request for Detailed TOC at databridgemarketresearch.com/toc/?dbmr=global-cell-based-...

Competitive Analysis:

The cell-based assays market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cell-based assays market for global, Europe, North America, Asia Pacific and South America.

Market Segmentation:

The cell-based assays market is segmented by product and services into consumables, instruments, services and software. Consumables are sub segmented into reagents, assay kits, microplates, cell lines, probes& labels and others. Assay kits are further sub segmented into reporter gene assays, cell growth assays, second messenger assays, cell death assays and others. Cell lines are further sub segmented into immortalized cell lines, primary cell lines and stem cell lines.

By End User the market is segmented into:-

• Pharmaceutical & Biotechnology Companies,
• Academic & Government Institutions And
• Contract Research Organizations (CRO).

On the Basis of Application the market is segmented into:-

• Drug Discovery,
• Basic Research,
• Adme Studies and
• Predictive Toxicology.

Access Full Report at databridgemarketresearch.com/reports/global-cell-based-as...

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1403926 • Views: 736
More releasesMore releases

You can edit or delete your press release here: